{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:23:53Z","timestamp":1787635433363,"version":"build-2736575974"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:00:00Z","timestamp":1385424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>It is unknown how responsive the Fracture Risk Assessment (FRAX) tool is to osteoporosis treatment (OTX) or whether it can serve as a target for \u201cgoal-directed\u201d treatment. We studied 11,049 untreated women aged \u226550 years undergoing baseline and follow-up DXA examinations in Manitoba, Canada. We identified clinical risk factors, intervening OTX based on medication possession ratios (MPR), and incident fractures. FRAX scores for major osteoporotic and hip fractures were computed for each scan using the most current (updated) FRAX inputs. Over 4 years, median FRAX scores showed an increase of 1.1% for major fractures and 0.3% for hip fractures, including women highly adherent to OTX (0.6% and 0.1% increases). Few (2.2%) highly adherent women had a decrease in major fracture probability exceeding 4%, whereas 9.0% had a decrease in hip fracture probability exceeding 1%. Compared with untreated women, OTX was associated with a higher dose-dependent likelihood of attenuating the expected increase in major fracture risk: adjusted odds ratios (aOR) 2.3 (95% confidence interval [CI] 1.8\u20132.9) for MPR &amp;lt;0.50; 7.3 (95% CI 5.6\u20139.6) for MPR 0.50\u20130.79; and 12.0 (95% CI 9.5\u201315.2) for MPR \u22650.80. In the 4 years after the second DXA scan, 620 (6%) women had major fractures (152 hip fractures). FRAX scores were strongly predictive of incident major fractures (adjusted hazard ratios [aHR] per SD increase in FRAX 1.8, 95% CI 1.7\u20131.9) and hip fractures (aHR per SD 4.5, 95% CI 3.7\u20135.7); however, change in FRAX score was not independently associated with major fracture (p\u2009=\u20090.8) or hip fracture (p\u2009=\u20090.3). In conclusion, FRAX scores slowly increased over time, and this increase was attenuated but not prevented by treatment. Few women had meaningful reductions in FRAX scores, and change in FRAX score did not independently predict incident fracture, suggesting that FRAX with BMD is not responsive enough to be used as a target for goal-directed treatment. \u00a9 2014 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2151","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T06:28:43Z","timestamp":1385447323000},"page":"1074-1080","source":"Crossref","is-referenced-by-count":31,"title":["Can Change in FRAX Score Be Used to \u201cTreat to Target\u201d? A Population-Based Cohort Study"],"prefix":"10.1093","volume":"29","author":[{"given":"William D","family":"Leslie","sequence":"first","affiliation":[{"name":"University of ManitobaWinnipegCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit R","family":"Majumdar","sequence":"additional","affiliation":[{"name":"University of AlbertaEdmontonCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M","family":"Lix","sequence":"additional","affiliation":[{"name":"University of ManitobaWinnipegCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne N","family":"Morin","sequence":"additional","affiliation":[{"name":"McGill UniversityMontrealCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Johansson","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Metabolic Bone DiseasesSheffieldUnited Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Od\u00e9n","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Metabolic Bone DiseasesSheffieldUnited Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene V","family":"McCloskey","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Metabolic Bone DiseasesSheffieldUnited Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Kanis","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Metabolic Bone DiseasesSheffieldUnited Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"key":"2024020318532822200_jbmr2151-bib-0001","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","article-title":"FRAX and its applications to clinical practice","volume":"44","author":"Kanis","year":"2009","journal-title":"Bone."},{"key":"2024020318532822200_jbmr2151-bib-0002","volume-title":"Clinician's guide to prevention and treatment of osteoporosis","author":"National Osteoporosis Foundation","year":"2013"},{"key":"2024020318532822200_jbmr2151-bib-0003","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","article-title":"2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"182","author":"Papaioannou","year":"2010","journal-title":"CMAJ."},{"key":"2024020318532822200_jbmr2151-bib-0004","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jbmr.1854","article-title":"Goal directed treatment of osteoporosis","volume":"28","author":"Cummings","year":"2013","journal-title":"J Bone Miner Res."},{"key":"2024020318532822200_jbmr2151-bib-0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jbmr.1859","article-title":"Goal directed therapy in osteoporosis","volume":"28","author":"McCloskey","year":"2013","journal-title":"J Bone Miner Res."},{"key":"2024020318532822200_jbmr2151-bib-0006","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","article-title":"Treatment failure in osteoporosis","volume":"23","author":"Diez-Perez","year":"2012","journal-title":"Osteoporos Int."},{"key":"2024020318532822200_jbmr2151-bib-0007","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1359\/jbmr.2003.18.6.1146","article-title":"Surrogates for fracture endpoints in clinical trials","volume":"18","author":"Khosla","year":"2003","journal-title":"J Bone Miner Res."},{"key":"2024020318532822200_jbmr2151-bib-0008","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jc.2011-2871","article-title":"Rate of bone density change does not enhance fracture prediction in routine clinical practice","volume":"97","author":"Leslie","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318532822200_jbmr2151-bib-0009","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-125-7-199610010-00011","article-title":"Surrogate endpoints in clinical trials: are we being misled","volume":"125","author":"Fleming","year":"1996","journal-title":"Ann Intern Med."},{"key":"2024020318532822200_jbmr2151-bib-0010","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jama.282.8.771","article-title":"How to use an article measuring the effect of an intervention on surrogate endpoints","volume":"282","author":"Bucher","year":"1999","journal-title":"JAMA."},{"key":"2024020318532822200_jbmr2151-bib-0011","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1371\/journal.pmed.0040250","article-title":"How evidence-based are the recommendations in evidence-based guidelines","volume":"4","author":"McAlister","year":"2007","journal-title":"PLoS Med."},{"key":"2024020318532822200_jbmr2151-bib-0012","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-011-1592-3","article-title":"High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice","volume":"23","author":"Leslie","year":"2012","journal-title":"Osteoporos Int."},{"key":"2024020318532822200_jbmr2151-bib-0013","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jc.2011-3055","article-title":"Heart failure is a clinically and densitometrically independent risk factor for osteoporotic fractures: population-based cohort study of 45,509 subjects","volume":"97","author":"Majumdar","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318532822200_jbmr2151-bib-0014","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/JCD:8:1:025","article-title":"Construction and validation of a population-based bone densitometry database","volume":"8","author":"Leslie","year":"2005","journal-title":"J Clin Densitom."},{"key":"2024020318532822200_jbmr2151-bib-0015","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/archinte.167.15.1641","article-title":"Single-site vs multi-site bone density measurement for fracture prediction","volume":"167","author":"Leslie","year":"2007","journal-title":"Arch Intern Med."},{"key":"2024020318532822200_jbmr2151-bib-0016","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/jbmr.123","article-title":"Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration","volume":"25","author":"Leslie","year":"2010","journal-title":"J Bone Miner Res."},{"key":"2024020318532822200_jbmr2151-bib-0017","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00198-010-1465-1","article-title":"Fracture prediction and calibration of a Canadian FRAX\u00ae tool: a population-based report from CaMos","volume":"22","author":"Fraser","year":"2011","journal-title":"Osteoporos Int."},{"key":"2024020318532822200_jbmr2151-bib-0018","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jbmr.1582","article-title":"Does osteoporosis therapy invalidate FRAX for fracture prediction","volume":"27","author":"Leslie","year":"2012","journal-title":"J Bone Miner Res."},{"key":"2024020318532822200_jbmr2151-bib-0019","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jbmr.1472","article-title":"Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures","volume":"27","author":"Austin","year":"2013","journal-title":"J Bone Miner Res."},{"key":"2024020318532822200_jbmr2151-bib-0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1359\/jbmr.070905","article-title":"Recommendations for the clinical evaluation of agents for treatment of osteoporosis","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res."},{"key":"2024020318532822200_jbmr2151-bib-0021","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00198-009-0838-9","article-title":"Bone turnover markers: understanding their value in clinical trials and clinical practice","volume":"20","author":"Civitelli","year":"2009","journal-title":"Osteoporos Int."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2151","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/29\/5\/1074\/56565919\/jbmr2151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/29\/5\/1074\/56565919\/jbmr2151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:51:18Z","timestamp":1710341478000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/29\/5\/1074-1080\/7598966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,11,26]]},"published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2151","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,5,1]]},"published":{"date-parts":[[2013,11,26]]}}}